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The resistant (R) and intermediate (I) stratus are shown in the Table.
Conclusions: Pneumococcal strains causing localized or invasive infections
in the child population of the study area, do not currently present with
considerable resistance to the commonly used antibiotics. However. cautious
administration of antibiotics and resistance surveillance should remain in
high priority.
Oxa 1.3 20
PG 1.3 4 7.2 0.19-1.0 12.7 3-6
TX
EM 1.3 3 21.8 0.5 4.5 1.5-4.0
CL 1.3 12 0.9 16
TS 1.3 4 3.6 1-2 0.9 4
VA
Aim: The aim ofthis present study was to investigate the susceptibility ofS.
pneumoniae among children ofNW Greece during the decade 1990-1999.
Method: A total of185 strains ofS. pneumoniae were isolated and divided in
two groups. Group 1: blood/cerebrospinal fluid cultures (n = 75) and Group
2: ear/eye swabs (n = 110). The susceptibility to Penicillin was initially tested
with the disk diffusion method [1 J.Lg Oxacillin (Oxa) disk], according to the
NCClS standards. E-test strips for Penicillin (pG) and Ceftriaxone (TX)
furthermore confirmed the resistant strains. The sarne method was used for
the susceptibility of all strains to Erythromycin (EM), Chloramphenicol
(Cl), Vancomycin (VA), and Tri/Sulfa (TS).
I
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IWeP220 lin vitro activity of various antimicrobials against
Burlcholderia cepada isolates from blood cultures and wounds
L. Stebaeva, T. Guskova
TsKhLS- VNIKhFl, Moscow, Russian Federation
Objectives: E is a chemical compound of 3-oxypyridine class and a
structural analogue to vitamin B6. It has wide range of biological activity.
E ingibits free-radical oxidation, stabilizes the membrane structures. The in
vitro of E on the phagocytic and bactericidal activity of macrophagcs,
hydrophobic and adhesive properties of the cells been studied in the present
study.
Methods: The effect of the E on the ultrastructure of the bacterial cell has
been studied. Changes in the bacterial cells under the E action on dependend
concentration of thes drug. In contact of E with St. aureus the changes
developed on enlargement of the cells thickening of the ealls, picnosis of the
nuc1eoitide and thinning of the cell wal with the festoon-like cell appearing.
The changes in the structure of Ps. aeruginosa under the E influence were
restricted to the appearance offestoon-like, sharply elongated fibriform cell.
Results: The data obtained withes to a complex effect of E on the bacterial
cells. The results obtained make in possible to advise the use of E for the
treatment of infection disease.
IWeP21911n vitro effect of emoxypin (E) on bacterial cells
Conclusions: At conditions simulating the in vivo environment GlA and
AA render C and A considerably potent.
M. Gueorguieva-Sredkova, S. Mihailova, V. Edreva, A. Chervenkova, S.
Stojcheva
Higher Medical Institute, Pleven, Bulgaria
Objectives: To study the activity often antimicrobial drugs against B.
cepacia isolates from blood cultures and wounds.
Methods: Thirty-six strains of B. cepacia isolated from blood cultures (29
strains) and wounds (7 strains) were studied. The MICs of azlocilline,
piperacilline, cefoperazone, ceftazidime, cefepime, imipenem, meropenem,
gentamicin, amikacin, and ciprofloxacin were determined by an agar
dilution method according to NCClS recommendations.
Results: Meropenem, imipenem, and ciprofloxacin were the most active
agents with MIC90s = 2 J.Lg/ml. MIC90-values of the cephalosporins
ceflazidime and cefepime, and piperacilline were 4 J.Lg/rnI, whereas
MIC90s of cefoperazone and azlocilline were higher (16 J.Lg/ml and 8 lAg/
ml respectively). The aminoglycosides showed lower activity with MIC90-
values of16 J.Lg/ml for gentamicin and 32 J.Lg/ml for amikacin.
Conclusions: The results of this study show that carbapenems and cipro-
floxacin are the most effective drugs against B. cepacia followed by
ceftazidirne, cefepime, and piperacilline.
IWeP221 I Susceptibility to antibiotics of 185 S. pneumoniae
strains Isolated from a child population of NW Greece
A. Eleftheriou, E. Galanakis, E. Themeli, C. Pappa, E. GesouIi, S.
levidiotou
Department ofMicrobiology, University Hospital, Ioannina, Greece
IWeP222I Phages types. ability to produce siderophore.
susceptibility to antibiotics and heavy metals of methidllln-
resistant Staphylococcus aureus strains
D. Torumkuney-Akbulut. O. Ang, M. Ang-Kucuker
Istanbul, Turkey Medical Faculty, Department ofMicrobiology
Objectives: A total of 45 methicillin-resistant Staphylococcus aureus iso-
lated from different specimens were examined according to their phage
types, ability to produce siderophore, susceptibility to antibiotics and heavy
metals.
Methods: 45 Staphylococcus aureus isolates were identified by using con-
ventional methods. The isolates were phage-typed by phage typing method
as decribed by Adams and Anderson. for detection of sidorophore produc-
tion the chorom azurol S (CAS) agar was used as described by Schwyn and
Neilands. The cross- feeding bioassay of Hantke was done for detection
enterobactin production. The susceptibility of bacteria to heavy metals as
described by Nies D.H.• Silver S. for detection of antibiotic susceptibility
was done by using agr dilution method.
Results: Ofthe 45 isolates, according to the result ofphage typing, six found
to belong to Phage-Group I, two were from Phage-Group III, six were from
the mixt phage group. 31 of the 45 strains were found untypabled.
According to results ofsusceptibility tests, all strains were found susceptible
to vancomycin and teicoplanin. The highest rate ofresistance was described,
respectively, for penicillin (88.8%), tetracyclin (82.2%). gentamicin
(77.7%), cadmium nitrat (71.1 %), ciprofloxacin (64.4%), clindamicin
(40%). erythromycin (37.7%), sodium arsenat (13.3%) and mercury chlorur
(2.2%) 42 of the 45 Staphylococcus aureus strains produced sidorophores.
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IMo0141 Eects of astaxanthln and vitamin Cagainst H. pylori
infection in Balb/cA mice
X. Wang1, R. Willcn2, T. Wadstrom l
I University of Lutld, Lund; 2Sahlgrenska Utliversity Hospital, Gothenburg,
Sweden
Background: Helicobacter pylori infections in human is associated with
chronic type 11 gastritis, peptie ulcer disease and g~stric carcinoma. A high
retake of carotenoids and vitamin C have been proposed to prevent
development of gastric malign~ncies.
Objective: To explore ifa) the micro algae Haematococcus pluvialis rich in the
carotenoid astaxanthin; b) vitamin C can inhibit experimental H. pylori
infections in a BAlB/cA mouse model.
Methods: Six-week-old BAlB/cA mice were infected with a mouse
passaged H. pylori strain 119/95. At two weeks post-inoculation mice were
treated orally once daily for 10 days with different doses of astaxanthin (10,
50 and 100 mg/kg body weight) or vitamin C (400 mg/kg body weight).
Half of the animals from each group were sacrificed immediately after the
treatment and the other halfwere sacrificed 10 days later (n = 10 per group).
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Gastric cultures of H. pylori and histopathology were used to follow this
study.
Results: Mice treated with astaxanthin or vitamin C showed significantly
lower colonization compared to the H. pylori infected control animals
immediately after treatment and 10 days post-treatment. The inflammation
score was significantly lower in the astaxanthin or vitamin C treated animals
than in the infected control mice. A dose of 100 mg/kg of astaxanthin was
found to be the most effective compared to 10 and 50 mg/kg body weight.
However, an inhibitory effect was even seen with the lowest dose (10 mgt
kg).
Conclusion: Nature antioxidants may be a new and exciting field for
treating H. pylori induced infections in humans.
IMo01S1 Bactericidal activity of LY333328 for experimental S.
pneumoniae meningitis
J. Gerberl , A. Smirnovl,J. Ragheb', K. Wettich2, S. Kalich2, R. Naul
/Dept. ofNeurology. University ofGOllingen; 2UlIy Deutschland GmbH. Bad
Homburg. Germany
Objective: To study the activity ofLY333328 against S. pneumoniae in an in
vivo model ofS. pneumoniae meningitis.
Methods: NZW Rabbits were infected intracisternally with 106 CFU of a
penicillin-sensitive S. pneumoniae type 3 strain (MIC for LY333328 = 0.015
mg/I, MBC = 0.03 mg/l). At 12 h after infection, they were treated with a
single dose ofLY333328 [l mg/kg (n = 5),2.5 mg/kg (n = 5), 10 mg/kg (n
= 10), 40 mgfkg (n = 2)] over 30 min. Controls received a bolus of
ceftriaxone (20 mgfkg) followed by a continuous infusion ofl0 mg/kgfh (n
= 12). CSF was drawn at 12, 14, 17.20, and 24 h for the determination of
bacterial titers, leukocyte densities, lipoteichoic/teichoic acid. lactate. protein
and antibiotic concentrations. The concentration of neuron-specific enolase
in CSF was measured at 24 h. Concentrations ofLY333328 were determined
by liquid chromatography/mass spectroscopy. Bactericidal activity in CSF
was estimated by log-linear regression of bacterial titers versus time.
Additionally, time-kill curves were performed with 10 mg/l LY333328.
Results: In-vitro, 10 mg/l of LY333328 killed S. pneumoniae within 1 h,
whereas cultures treated with 10 mg/I ceftriaxone were sterile after 12 h. A
single dose of 10 mg/kg and 2.5 mg/kg of LY333328 reduced the CSF
bacterial titers as rapidly as ceftriaxone 10 mgfkg/h (aIog CFU /ml/h ± SD:
-0.29 ± 0.21 and -0.26 ± 0.22 versus -0.33 ± 0.15). Protein, lactate and
lipoteichoic/teichoic acid concentrations in CSF showed no significant
differences. The entry into the CSF as estimated by AUCCSFI2-24 h/
AUCSI2-24 h in most cases was between 1 and 5%. A dose of 40 mg/kg
LY333328 reduced the bacterial titers by -0.52 ± 0.02 ding CFU/ml/h. A
dose of 1 mg/kg was only bacteriostatic (aIog CFU/ml/h ± SD: O.ot ±
0.11). The half-maximal dose (KD) and the maximum bactericidal rate
(Emax) ofLY333328 as estimated by Lineweaver-Burk plot were 4.6 mg/kg
and -0.68 ~Iog CFU/ml/h, respectively. Parameters of neuronal damage
were not significantly reduced in LY333328-treated animals.
Conclusion: The in-vivo activity suggests that LY333328 may qualify for
the treatment of S. pneumoniae meningitis. The inflammatory reaction
during treatment with LY333328 was comparable to that during ceftriaxone
therapy.
IMo0161 Treatment of methidllin-resistant Staphylococcus
aureus experimental osteomyelitis with linezolid or vancomydn
K. E. Piper, M. S. Rouse, W. R. Wilson,). M. Steckelberg, R. Patel
Mayo Clinic, Roches/er. MN. United States
Linezolid (an oxazolidinone antibiotic) is reportedly active in vitro against
methicillin-resistant S. aureus (MRSA). MICfMBC's were performed using
a microdilution method described by NCCLS document M7-A4 with an
inoculum of 5 X 105 cfulml. The MIC90/MBC90 of 26 clinical isolates of
MRSA was 8/ > 8 (range 2-8/4- > 8) JIg/ml oflinezolid (LN) and! (range
0.125-1/0.5-4) Jlg/ml of vancomycin (VN). We compared the activity of
LN or VN in a rat model of MRSA experimental osteomyelitis. The MICf
MBC ofthe MRSA studied in vivo was 2/ > 8 JIg/ml ofLN and 0.5/0.5 JIg/
ml of VN. Experimental osteomyelitis was established in Wistar rats by
inoculating a sclerosing agent and 8 X 106 efu of MRSA into the medullary
cavity of the proximal left tibia. Four weeks after infecting the rats,
treatment was initiated with no treatment, LN 25 mg/kg IP bid, LN 25
mg/kg IP tid or VN 25 mg/kg IP tid. After 21 days treatment, rats were
sacrificed; the tibiae were aseptically removed and cultured quantitatively.
Results of treatment were expressed as logto cfu/g bone and analyzed by
rank sum analysis. The mean 30 minute serum concentration (3 infected ratS
after 6 days treatment) was 16.5 JIg/ml of LN given tid and 47.0 JLg/ml of
VN. The mean 60 minute serum concentration was 21.4 JLg/ml ofLN given
tid and 17.1 JLg/ml ofVN. The mean (n = 3) 6 hour serum concentration
was 3.70 JLg/ml ofLN and nondetectable by bioassay for VN. The AUCo-
24 of bath LN and VN was calculated to be > 100 JLg/ml/hr. The median
log10 cfu/g bone was 5.55 for control (n = 29),5.80 for LN bid (n = 18),
4.67 for LN tid (n = 18) and 5.61 for VN (n = 17). The range 25th-75th
percentiles were 5.10-6.29 10glO cfu/g bone for control, 5.14-6.14 log10
cfu/g bone for LN bid, 3.99-5.3210glO cfu/g bone for LN tid and 4.87-5.97
10glO efu/g bone for VN. The MRSA MIC post treatment was 2 JIg/ml of
LN and 0.5 JLg/ml of VN. In the treatment of MRSA experimental
osteomyelitis LN given tid was more effective (P < 0.05) than control,
but was not significantly different (P = NS) than VN. VN was not
significantly different (P = NS) than control.
IMoO171 Invalidation of in-vitro susceptibility testing of
Aspergillus flavus with itraconazole and amphoteridn B using a
murine model
J. Mosquera', P. Warn', C. Moorel• C. Lamaignere2, D. Denningl
lUniv. ofManchester, United Killgdom; 2Univ. of Thessaloniki, Greece
Objectives: Using a murine model, attempt to validate Aspergillusflavus in-
vitro susceptibility testing, by examining three in-vitro methodologies
developed for A ..fumigatus.
Methods: 8 A.flavus strains with a variety ofsusceptibilities to amphotericin
B (AMB) and itraconazole (ITZ), were tested with three in-vitro suscept-
ibility testing methods in microtitre format, including the NCCLS M38-P.
One had been previously validated for A ..fumigatus and is able to detect ITZ
resistance in-vitro (method A). Main variations were inoculum size. endpoint
interpretation and addition of2% glucose.
Using method A, the isolate AFL5 was putatively resistant to AMB and
AFL8 to ITZ. Both were placed in an animal model. Mice were immuno-
suppressed with cyclophosphamide, infected three days later via the tail vein
and treated with either AMB (5,2 or 0.5 mg/kg per dose) or ITZ (75.25 or
15 mg/kg per dose).
Results: Both isolates were susceptible in-vivo to AMB and ITZ. All in-vitro
methods incorrectly assigned isolate AFL5 as AMB resistant. Method A gave
variable and unreliable results for ITZ with A.flavus. as trailing endpoints
and sedimented spores were problematic when using a high final inoculum
(5 x 10' CFU/ml). A lower inoculum (2.5 X 104) was superior. In separate
experiments changes in the inoculum induced large variations in ITZ MIC
against A. flavus.
Condusions: The NCCLS M-38P method does not correlate with the in-
"ivo outcome using AMB. A final inoculum of2.5 X 104 CFU/ml should
probably be employed when testing ITZ against A. j1avus. A genuinely
resistant strain is required to fully validate the NCCLS or any other
methodology against ITZ. AMB and ITZ appear effective in the treatment
of A. jlavus infections.
IMo0181 Drug-induced reactivation of chronic murine
toxoplasmosis
V. Milenkovic. O. Djurkovic-Djakovic
Illstitutefor Medical Research. Belgrade. Yugoslavia
Objective: To develop a murine model ofreactivated chronic toxoplasmosis
mimicking this life-threatening condition in immunosuppressed humans.
Methods: Groups of female Swiss-Webster mice infected intraoesophage-
ally 6 wks previously with 10 cysts of the Me49 strain of Toxoplasmagolldii
were treated with dexamethasone (DXM, 5 mg/L of drinking water),
cortisone-acetate (CA, 50 mgfkgBM by subcutaneous injection 3 times/
wk), and with both drugs combined (DXM + CA) during 8 wks.
Morbidity and mortality were recorded daily. In all dying mice as well as
in euthanized 8-wk survivors, brain homogenates were examined for cyst
enumeration, and, as measures of immune reactivity, index of spleen (mg)/
8M (g) (Is/m) was calculated and total spleen cells counted. Immunosup-
pression was funher assayed in groups of7-wk survivors by intraperitoneal
inoculation of 102 tachyzoitcs of the mouse-virulent RH strain of T. gondii.
Results: In all treatment groups, mortality began after 2 wks and was the
highest between wks 4 and 6, amounting to 70% in the DXM and 88% in
the DXM + CA group by the end of the experiment. CA treatment alone
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led to only sporadic deaths. In both the DXM and DXM + CA groups, cyst
numbers were increased, to a mean of 1285 and 548, respectively, vs. 130 in
infected non-treated mice. Is/m in the DXM (3.82) and DXM + CA (3.65)
groups were significantly lower (p < 0.0001) as compared to both infected
non-treated (12.9) and non-infected non-treated (7.78) mice. Likewise,
spleen cell counts were significantly (p < 0.05) reduced in both DXM
(1.18 x 107) and DXM + CA (1.55 x 107) groups compared to infected
nontreated mice (3.52 x 10\ Furthermore, while challenge with RH
tachyzoites killed all non-infected non-treated mice within 10 days, and
infected nOll-treated micc were partially immunised (4/6 survived 6 weeks),
all infected treated mice succumbed to acute toxoplasmosis within 4 days.
Condusions: This simple model of drug-induced reactivation of chronic
toxoplasmosis may provide a useful tool for in vivo studies of the pathoge-
netic mechanisms of T. gOlldij stage-conversion, as well as for the evaluation
of chemotherapeutics.
lMo01~ Specific human antibody response in trimera mice
immunized with antigen pulsed-dendrltlc cells
R. Kovjazin, N. Rachamim
XTL Biopharm, Rehovot, Israel
Objectives: The Trimera system enables the adoptive transfer of human
peripheral blood mononuclear cells (PBMC) into normal mice lethally
irradiated and radioprotected with SCID mouse bone marrow cells. This
system was described as a tool for developing high affinity, fully human
monoclonal antibodies and applied for the generation ofhuman monoclonal
antibodies specific to hepatitis B surface antigen (HBsAg). Our purpose was
to induce specific human immune responses by immunizing Trimera mice
with antigen (Ag) - pulsed dendritic cells (DC).
Methods: Antigens used for loading DC were Hepatitis B surface antigen
(HBsAg). complex HBsAg-specific human IgGI monoclonal antibody
(HBsAg-Ab). HCV envelope protein E2 and complex E2-specific human
IgGl monoclonal antibody (E2-Ab). Trimera mice were transplanted i.p
with PBMC from donors postive to HBsAg and to E2. Mice were
subsequently immunized with Ag-pulsed DC and boosted 4-5 days later.
Mice were bled 18 days after immunization and their sera were tested for the
presence of human specific antibodies by ELISA.
Results: Extremely high amplification of human antibody responses to
HBsAg (780-123000 fold) and to E2 (55-520 fold) was observed in DC
immunized mice as compared to the levels ofantibodies in the donors sera.
Condusions: These results demonstrate efficient antigen presentation by
human DC to autologous lymphocytes in vivo indicating that Ag-pulsed
DC could serve as powerful immunogens.
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IMoP1551 Clinical eects of infections with bacterial filaments
and spheroplasts in neutropenic mice
]. Buijs', A. S. M. Dofferhoff'i" M. Moutonl,]. W. M. van der Meer2
ICanisius-Wilhelmilla Hospital; University Medical Celller, Nijmegen,
Netherlands
Objectives: Antibiotic-induced filament formation by Gram-negative bac-
teria may cause massive endotoxin-release with subsequent clinical deterior-
iation. However, clinical data on filament pathogenicity and growth
capacity lack.
Methods: We studied the effects of injections of E. coli ATCC 25922
filament-suspensions and spheroplasts in thigh muscles of 36 neutropenic
Swiss mice, compared to injections ofmorphologically unchanged bacteria.
Inocula were prepared by exposing an overnight culture to 0.5 x MIC
ceftazidime, 0.5 x MIC meropenem, or no antibiotic to obtain bacterial
filaments, spheroplasts and normal bacteria, respectively. After 4 hours of
incubation, inocula were washed with saline and injected into the left thigh
muscle. Murine survival was documented in 4 mice per group to a total of12
mice. The remaining 24 mice were sacrificed at 24 bours for histological and
bacteriological examinations and measurements of plasma and local endo-
toxin-levels.
Results: CFU levels in thigh muscle and spleen did not differ in the three
groups. Outgrowth in liver was significantly higher in controls (p = 0.(05).
Plasma endotoxin-concentrations tended to be higher in the filament-group,
compared to the spheroplast-group (p = 0.07). There was no difference in
survival between the groups. On histological examinations at 24 hours, no
ftlaments were found, only morphologically normal bacteria.
Conclusions: Bacterial filaments and spheroplasts are capable of regaining
normal bacterial growth. Filaments indeed seem to induce higher plasma
endotoxin-concentrations. Morphologically altered bacteria disseminate less
to liver than controls. They are still pathogenic, not only by their capability
of endotoxin liberation, but also by growth capacity.
IMoP156! First demonstration of in vivo antibiotic-induced
filament-formation
]. Buijsl, A. S. M. Dofferhoff,]. W. Mouton', B.]. Kullberg2,j. W. M.
van der Meer2
'Canisills-Wilhrlmi,ra Hospital; 2University Medical Center, Nijmegtn,
Netherlands
Objectives: 13-laetam-antibiotics are known for their ability to induce
morphological changes in Gram-negative bacteria, as a result of binding
to Penicillin-Binding Proteins (PBP). In vitro studies showed formation of
long filamentous bacteria after exposure to a PBP-3 binding antibiotic like
ceftazidime. Tbis was related to high endotoxin-concentrations, whicb
might be clinically disadvantageous. In spite of these observations, m-vivo
observations of filament-formation are lacking.
Methods: Twelve neutropenic Swiss mice were divided into two tF--0ups
receiving a suspension ofE. coli ATCC 25922, in a dosage of 1 x 10 CFUI
mouse intraperitoneally or intramuscular in the left thigh muscle, respec-
tively. Two hours after inoculation each animal received an injection of
ceftazidime 20 mgJkg. After 2 hours 3 animals ofeach group were sacrificed
for measurements ofbacterial outgrowth, histology and bacterial morphol-
ogy in liver. spleen, muscle and peritoneum. In addition, plasma endotoxins
were measured. After 4 hours the remaining 6 mice were sacrifieed for the
same measurements.
Results: Four hours after injection ofceftazidime, large filaments were seen
in HE-stained histological material of the thigh muscle. Shorter filaments
were seen intraperitoneally. With this technique it was not possible to
visualize bacteria in liver and spleen. Bacterial counts showed a significant
higher outgrowth ofCFU's in liver and spleen oftbe peritonitis-group.
Conclusions: Ceftazidime reduces formation of large filaments in vivo at
clinically relevant dose-levels. This phenomenon might have hazardous
effects on the host, by the possibility ofhigh endotoxin-release.
IMoP157! Treatment of experimental endocarditis due to
ceftrlaxone and penidllin-resistant Streptococcus pneumoniae
F. Lopez-Fornas, F. Martinez, A. Garcia, D. Roldan,]. Perez, D. Pascual,
A. GOmez,]. Ruiz, M. Valdes
Hospital Virgen de la A"ixaca, Murcia, Spain
Objectives: comparative study oftreatment with Penicillin, Trovafloxacin,
Ceftriaxone, Vancomicyn and Quinupristin-Dalfopristin in the Experimen-
tal Endocarditis in rabbits due to Ceftriaxone and Penicillin-Resistant
Streptococcus pnellmoniae serotype 19
Methods: the animals were treated with one of the following programs in
comparison witb a control group which did not receive treatment: Penicillin
G procaine (16 rabbits) 300.000 u/kg/12 him; TrovaBoxacin (31 rabbits) 13.3
mg/kg/12 h iv; Ceftriaxone (21 rabbits) 75 mg/kg/24 b iv; Vancomycin (15
rabbits) 20 mg/kg/12 h iv; Quinupristin-Dalfopristin (20 rabbits) 30 mg/Kgl
8 h im and control group (16 rabbits).
Results: AU the antibiotics used have been shown to be efficacy in reducing
the concentration of Streptococcus pneumolliae and increasing the level of
sterilization of the aortic vegetations. Vancomycin was tbe most efficient
drug in reducing bacterial level in the vegetations, it steriJizad 100% of the
animals. Quinupristin-Dalfopristin obtained, after Vancomycin, the greatest
reduction of the CFU/g of vegetation and managed to sterilized up to 85%
of the vegetations. Penicillin. at the dose used in our study, able to reach
blood concentrations levels of over 2 to 3 MIC, was shown to be an efficient
drug, it sterilizad 81 % of the vegetations.
Conclusions: Vancomycin and Quinupristin-Dalfopristin can be considered
valuable alternative to Penicillin in the treatment of these infectious.
